Language selection

Search

Patent 2012395 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2012395
(54) English Title: TOPICAL ANALGESIC COMPOSITION
(54) French Title: COMPOSE ANALGESIQUE TOPIQUE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 31/235 (2006.01)
  • A61K 47/10 (2017.01)
  • A61K 47/14 (2017.01)
  • A61K 47/18 (2017.01)
(72) Inventors :
  • WENIG, JEFFREY (United States of America)
  • ROMEO, VINCENT (United States of America)
(73) Owners :
  • NASTECH PHARMACEUTICAL CO.,
(71) Applicants :
  • NASTECH PHARMACEUTICAL CO., (United States of America)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1990-03-16
(41) Open to Public Inspection: 1990-09-17
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
07/324,912 (United States of America) 1989-03-17

Abstracts

English Abstract


ABSTRACT OF
THE
DISCLOSURE
Flowable, aqueous, analgesic solutions containing
substantially equimolar quantities of trolamine and
salicylic acid together with a lower alkanol, a lower
alkylene glycol and a lower alkyl ester of
parahydroxybenzoic acid and water, and method for the
preparation thereof.


Claims

Note: Claims are shown in the official language in which they were submitted.


WE CLAIM:
1. A flowable, analgesic, aqueous solution having a pH
of from about 6 to 8, a viscosity of from about 0.98 to 1.2 times
that of water and containing, from, about 5 to 12% trolamine,
about 3 to 10% salicylic acid, about 0.1 to 0.5% of a lower alkyl
ester of parahydroxybenzoic acid, abut 2.5 to 5% of a propylene
glycol or mixtures thereof, and about 3 to 6% of an alkanol
containing two or three carbon atoms, the salicyclic acid and
trolamine being present in substantially equimolar quantities.
2. A solution of claim 1 containing from 1% to 10%
molar excess of trolamine.
3. A solution of claim 1 or 2 wherein the alkyl group
of the lower alkyl ester of parahydroxybenzoic acid contains up
to three carbon atoms.
4. A solution of claim 1 or 2 wherein the propylene
gylcol in 1,2-propane diol.
5. A solution of claim 1 or 2 containing a mixture of
methyl and propyl esters of parahydroxybenzoic acid.
6. A solution of claim 1 or 2 containing a mixture of
ethyl and isopropyl alcohol.
7. A solution of claim 1 or 2 containing a mixture of
methyl and propyl parahydroxybenzoic acid together with,
isopropyl alcohol, and 1,2-propane diol.
8. A method for the preparation of an aqueous solution
of claim 1 dissolving the trolamine and salicylic acid in a
portion of the total water of the solution which will dissolve
all of the trolamine and salicylic acid to form a first mixture,
- 7 -

separately forming a second mixture containing the lower alkyl
ester of parahydroxybenzoic acid and the alkylene glycol;
combining the first and second mixtures at a rate which is
insufficient to cause precipitation of any solid and thereafter
adding the alkanol and any additional water necessary to form the
said aqueous solution.
9. A method of claim 8 employing from 1% to 10% molar
excess of trolamine.
- 8 -

Description

Note: Descriptions are shown in the official language in which they were submitted.


r-
Trolamlne sali~ylat- ha~ long b-sn known a~ a topl~-l
~n~lge~lc for temporary ~Qll~f o~ mu~culo~kol~t-l ~ch-~ and paln-q
~peclally tho~e a~soci~ted wlth tra~n~, ~praln~, brulo-~ or
ov~r-xcrtion, t ha~ alno b-on recomm-nd-d ~or ~empo~ary
allovlation o~ arthritlc ~nd rh~umatlc paln oDp~cially ln th-
h~nds and ~--t. It 18 ~peclally favor~d by atnlete~
Trolamine ~allcylAte 1~ a l:l complex formad by r-actlon o~
~qulmo~ar qu~ntitl~ of ~allcyllc acld ~nd trol~mlne (t~l-th~nol
amln~ ho analgesic a~-nt 18 the ~allcyllc acld which fo~m~ tn
JltU when th- Jalt cro~ th~ ~kln barrl-r,
The prlnclpal da~ld-ratum of toplcal analge~lc~ 1~ r~pld
p-n-tr~tlon of the ~ln barrler to th- r-glon of th~ paln. To
thlJ cnd, a variety o~ toplcal cr-am-~ lotiono, ~02m~ and othar
vl~cou~ oomposltlon~ hav- ~oon provid-d contalning a larg- numbe~
o~ omoli-nt-, suopon~lng agent~, eh-lating agents, ~t~ nlng
ag-nt~, omulsirl~r6, olls, buf~-rln~ agent4 and oth-r component~
lnc~udlng, 80 call-d ol~agonou~ v-hlcle~ hav~ bo-n provlded,
app~r~ntly in tho b-lle~ ~hat ~uch lngr~d~ont~ ~ro n0cos~ary ~or
r-pld penotrEtlon o~ th- ~kin barr~-r.
Th~- vl~cou~ compo-ltion~ ar- o~ten di~flcult to apply and
r~qulre xt~nslv~ "ru~blng ln". Thl~ may be burd~n~om~,
-p-clally lf ~oth hands ar~ ~ff-cted, o~ lf th- aff-cted ar~a 1
h-rd to r-ach ~uch ~Q the ~r of th~ ~houlter ar-~.
Addltlo~ally~ the cr~am may 1~aY~ un-~ght~y raoldu~ on ths 4~1n
or thoy may tain th~ clothl~g. Oft-n, -p~clally lf u~-d by nn
athl-t~ ~urlng comp~tltlon thoy may ab~orb ~lr-~orn~ du~t and
p-rtlcles and b-com~ n more unst~htly~ Mor-o w r, on~ or mor-
of the compon-nt~ m~y b- allorg~nlc.
. .

20~3~5
.
Th~ a~t h~ long ~earch-d ~or compo~ltlon- whlch can b~
u~erully mploy~d whil~ avoiding th~ ~bove mentionod
icultl~.
'
.
It ha~ now b--n dl~cov-r-d that ~ ~eapito th- lndl~atlon~
from the ~rt, aqu-ou~ oolutlon~ con~inin~ t~ol~m~n- ~all~yla~e
n--d ~ot contaln the larg- numbo~ of lngr-dl-~t~ pr~vlo~ly
mployed, but th~t th~ anAl~o~lc may b~ promptly and e~ ien~ly
d-llver~d to tho ~lt~ wh~ro it i3 naed6d ~rom ~ Garrlor baYe that
contain~ only w~tor, ~ pr~a-r~ti~e, ~ low~r alkanol, ~nd A low
mol-c~ wolght glycol. Th~ ~ctlv- l~gr~dlent w~ll r~pldly ~ -
pon~trate th- ~ln barrl~r to prov~ a prompt ~oothlng analgeoic
aetlon de~plt- tho absenc- o~ the oll~, ~mulsl~lar~ ~nd oth~r
xcipient~ norm~lly employ-d with trolamln- ~-licylAt-.
~ h~ compo~itlon. o~ th- inYentlon ar- ~low~bl- ~ompo~ltlon~
wlth a vl~co~ty at dmbl-nt t~mper~ture whloh 1~ ~out th~t of
w~ter, 1,~. ~bout 0.58 to 1.2 time~ th~ v~co~ity o~ water.
B~cau~e th-y are re~dlly flowable, 1.~., "llk- wat~r", tney may
be ~a~lly And convonl-ntly ~ppll~d by a ~-ry brief rubblng. Th-y
are r-~d~ly appll-~ ~om ea~lly d-~gn-d cont~l~er8 ~uch ~
~-rosol, bru~h or spongo ~ppllcator~. Tha volum- Or ~olutlon
p-e~lng through tho Appllcator c~n be controll~ by ~ny o~
numbe~ o~ v~lve mean~ w-ll known to tho~ d in tno art,
Some appllc~tor~ may ov-n ellminat- th- n-~d ~or touchlng th~
compo~ltlon~ of tho in~ent~on ~urtng ~ppllcat~on.
Tho ~ormatlo~ of th- trol~mine ~allcyl~t- ~omplsx ~3 ~n
qulmolar r~ctlon. Acco~dlngly the compo~ltlon~ will ~ontaln
~ub~t~ntlally e~ulmol~r quantlt~a~ o~ the ~n~lg-~lc ~Cld and th- :~
b-Jo. ~t 1- pro~rre~ to omploy ~ ght molsr xc~o~, 4ay 1~ to
-- 2 --

Z01~39S
10~, o~ th~ ba9e to insur~ th~t all 4~ the acld will r4act an~
301ubillz~, The amount of trolamlne wlll vAry ~rom ~bout 5 to
12~, and of ~allcylic acid from about 3 to lO~ by w~i~ht bo~ed on
tho total volum- o~ ~o oompo~tlon.
In thl- dl3closu~0 ond clolm~, all de~ined amount~ Aro tn
p-rcont by w-ight ba~ad on tho total volume.
Tho alkonol dmployod in th~ oomposltlonJ will contaln two o~
~hree corbon atom~ ~nd b~ misclbl- wlth wat~r. Such alcohols
hsve Low ~o~ling polnta and hlgh vapor p~e~sura. Th-y promo~e
ropld ~vaporation of th~ carrier v~hiol- ot ~he compo~ltion. The
amou~t o~ alcohol employed lo typlo~lly ~rom about 3 to 6~.
Th- pref~rr~d alkanol i~ l~opropyl alcohol. M~xtures of
alcohol~ w~ich ~oy contoln eth~nol moy b~ ~m~loy~d.
Tho compoJltion- ol the inv~ntlon wSll al~o cont-in A
pre~orv~ttve. Th- pr~o~tly pr-~-rr-d pre~rv~tlv-~ arc low~r
al~yl -ter~ of psrAhydroxyb-nzolc ocid, typlo~lly contalning up
to thræe carbon atom~, Th~ ~mount of pr-~arvatlv~ normally
employed will b~ ~rom about 0.1 to 0.5~, olthough wld- vorlation~
~re po~lble wlthout adverse re~ult~. The ~Jtar~ may be ~mploy-d
lngly, but lt i~ pr-~rr~d to u~- a mlxture o~ m-thyl and propyl
o~ter~ o~ p~rahydroxyben201c acl~ ~lnce tho mlxturo app~ar~ to ~e
moro ctlve than lt~e~ e~t~r t~ken ~lono.
Propyleno glycol~ or mlxtures ther~o~ are UtlllZ-~ ~n the
compo~ltlons o~ tho lnventlon ~- a ~olublll2~r for th~
pro~orvative ~y-t-m ln an amount of from ~out 2.5 to 6~. The
compo~ltlon8 of thl~ invontlon are solution~. It i~ lmport~nt
th~t ~11 of th- ~olid compon-~to dlJ~olv-~ A su~ficl-nt amount
of glycol 1~ mployed to ln~ure ~uch ~olublllty, but too much
- . ~ " j . . .

~ \
Z012395
glycol m~y incr~a~ the vi~co~ty of the composltion and ~tlll
decr~a~- the rata o~ evaporatlon rom ~he skln. ~h- pro~errod
g~ycol 1~ 1,2-propan~ dlol.
~ g lndlcAted abov-, the c~mpon-nt~ Or the mlxtur~ mu~t rorm
a oolutlon. It ha~ b--n dl~ov~r-d th~t th~ ~ethod o mlxlng i~
very lmport~nt to pr-v-nt pr~lplt~t~on o~ the ~olld compon-nt~.
In th~ pr-~orred procod~ro, th~ trol~mln- And ~allcyllo a~ld ~r-
~dded ~t amb~-nt temp~r~ture to th~ ct-d quantlty of wat~r,
which may be ~ll of th~ water employ~d ln th- compo~lt~on, and
the mlxtur~ 18 allow-~ to stand untll complete ~olut~on 1~
e~f~ct~d. A socond mlxtura contalnlng th~ aelect~d quantltl~s of
glycol and al~yl ~te~(~) o~ p~r~hydroxybenzolc acld, ~.q.,
mlxture o~ ~h- m~thyl and propyl estor 1~ ~-p~r~t~ly prep~r~d ~nd
~lowly adde~ to th- ~lr~t ~olutlon. I~ lt 1~ added too rapi~ly,
lt wlll c~u3e preclpltation o~th- ~llcyl~c acid ~nd/or the
alkyl o~ter o~ parahydroxyb-nzoic acid. Th~ glycollpreoe~vatlv-
m$xtu~e may con~in ~omo o~ tho water of th- ~lnal compo~lt~on.
Th- select~d quantlty o~ alkanol 1~ th~n ~ddcd ~o ehe mlxtur-.
Th~ p~ o~ th~ composlt~on~ oS thl~ inventlon ar- preSerably
a~ clo~c to n~utr~l a8 po4~1bl-, but a range oS 6 to 8, or evan
~llghtly wld~r c~n be to1crat-d.
It 1~ surprl~l~g to ob-~rve how qulckly the actlve
ln~r-dlent penotr~tes th~ a~ln basrl~r ~rom th- ~olutlon~ o~ thls
lnvention. Athl-t-~ hav~ b--n partlcul~rly ~-tl~led. ~h~y hdv~
ob~-rv-d rel~o~ ~rom musoular paln o~ the arm~ sn~ leg~ withln
few mlnute4 a~t-r toplcal ppllcation.
The.~ollowlng ~ormulatlon~ A ~nd B axo repre~ntatlv~ o~ the
~n-lgo~lc compo~ltlon~ o~ the i~vontlon.
,
-- 4 --
1 ' ' ' . ' . ' ' '' " ' ' '' '" ' ' ' "' ' ; ' . , ' ' ~ :

2 01~ 3 95
~ w/v
trol~mln- 99~ N.F. 5.76
~allcylle ~ld U.S.P. 4~1
m~thyl parahydroxyb~201c aci~, N,F. 0.2
propyl p~rahydroxybenzoic acid, N.F, 0.1
propylane ~lycol U.S.P. 3.0
lsopropyl ~lcohol U.S.P. 3.0
wat~r U.S.P. ~3.13
qr~ms
trolaml~e 9g~ N.F. 28. ~0
salleyllc ~ld U.~P. 2~05
methyl par~hydroxybenzole ~c~d, N.F. 1,00
propyl par~hydroxyben20~e ~cld~ N~F. 0.50
propylen~ glyeol U.~.P. 15.00
i~opropyl ~lcohol U.S.P. lS,00
wat~r U,S,P, ~1S.6S ~:.
For com~o~ltlon A, th- trolamlne, 50~ o~ th~ volume of wat~r
~nd thc ~llcjlic ael~ ~-ro ~tirro~ ~t room t-mporatur~ uns1l th- . :
~alleylic ~eid dl~-olv d. In ~ s~par~t- v~ l, th~
pr~J-rvatlve~ war- d~ol~d in propylo~e qlycol and th~
~olution ~d~ed ~lowly to th~ ~lr~t mlxtu~e wlth ~t~:rlng. ~hen ~:~
th~ addlt~on wa~ compl-t~, tho alcohol w~ ~dd~d ~ollowod by th- ::
b~l~ne- o~ tho w-t-r whlle contlnually Jtlrring. :
- 5 ~

20~239.~
CompoNltlon B tqa~ ~imil~rly prepar~d.

Representative Drawing

Sorry, the representative drawing for patent document number 2012395 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC deactivated 2011-07-26
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: First IPC derived 2006-03-11
Time Limit for Reversal Expired 1992-09-16
Application Not Reinstated by Deadline 1992-09-16
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1992-03-16
Inactive: Adhoc Request Documented 1992-03-16
Application Published (Open to Public Inspection) 1990-09-17

Abandonment History

Abandonment Date Reason Reinstatement Date
1992-03-16
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
NASTECH PHARMACEUTICAL CO.,
Past Owners on Record
JEFFREY WENIG
VINCENT ROMEO
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

({010=All Documents, 020=As Filed, 030=As Open to Public Inspection, 040=At Issuance, 050=Examination, 060=Incoming Correspondence, 070=Miscellaneous, 080=Outgoing Correspondence, 090=Payment})


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1990-09-16 1 39
Claims 1990-09-16 2 49
Drawings 1990-09-16 1 9
Descriptions 1990-09-16 6 233